U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.5270A>G (p.Tyr1757Cys) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 20, 2025
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001192505.5

Allele description [Variation Report for NM_000059.4(BRCA2):c.5270A>G (p.Tyr1757Cys)]

NM_000059.4(BRCA2):c.5270A>G (p.Tyr1757Cys)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.5270A>G (p.Tyr1757Cys)
HGVS:
  • NC_000013.11:g.32339625A>G
  • NG_012772.3:g.29146A>G
  • NM_000059.4:c.5270A>GMANE SELECT
  • NP_000050.2:p.Tyr1757Cys
  • NP_000050.3:p.Tyr1757Cys
  • LRG_293t1:c.5270A>G
  • LRG_293:g.29146A>G
  • LRG_293p1:p.Tyr1757Cys
  • NC_000013.10:g.32913762A>G
  • NM_000059.3:c.5270A>G
  • p.Y1757C
Nucleotide change:
5498A>G
Protein change:
Y1757C
Links:
dbSNP: rs587776466
NCBI 1000 Genomes Browser:
rs587776466
Molecular consequence:
  • NM_000059.4:c.5270A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001360691Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jan 20, 2025)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.

Yurgelun MB, Allen B, Kaldate RR, Bowles KR, Judkins T, Kaushik P, Roa BB, Wenstrup RJ, Hartman AR, Syngal S.

Gastroenterology. 2015 Sep;149(3):604-13.e20. doi: 10.1053/j.gastro.2015.05.006. Epub 2015 May 14.

PubMed [citation]
PMID:
25980754
PMCID:
PMC4550537

Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2.

Hwang SM, Lee KC, Lee MS, Park KU.

Cancer Res Treat. 2018 Jan;50(1):255-264. doi: 10.4143/crt.2017.062. Epub 2017 Apr 7.

PubMed [citation]
PMID:
28392550
PMCID:
PMC5784618
See all PubMed Citations (4)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001360691.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: BRCA2 c.5270A>G (p.Tyr1757Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 250310 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.5270A>G has been reported in the literature in individuals who underwent multigene panel testing for breast/ovarian cancer (Hwang_2017, Gifoni_2022, Guindalini_2022) or Lynch syndrome (Yurgelun_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 35957908, 35264596, 28392550, 25980754). ClinVar contains an entry for this variant (Variation ID: 156170). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 25, 2025